CompletedPHASE2, PHASE3NCT04311697
Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
Studying Acute lung injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- APR Applied Pharma Research s.a.
- Principal Investigator
- Jonathan C Javitt, MD, MPH, MDNeuroRx, Inc.
- Intervention
- Aviptadil by intravenous infusion + standard of care(drug)
- Enrollment
- 203 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2020 – 2021
Study locations (10)
- St. Jude Medical Center, Fullerton, California, United States
- University of California - Irvine, Irvine, California, United States
- Miller School of Medicine / University of Miami Medical Center, Miami, Florida, United States
- Baptist Hospital of Miami, Miami, Florida, United States
- University of Louisville Hospital, Louisville, Kentucky, United States
- Heartland/Mosaic Health, Saint Joseph, Missouri, United States
- Hendrick Health, Abilene, Texas, United States
- Texas Health Harris Methodist Hospital, Fort Worth, Texas, United States
- Texas Health Hospital Frisco, Frisco, Texas, United States
- Houston Methodist Hospital, Houston, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04311697 on ClinicalTrials.govOther trials for Acute lung injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06526598Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) TrialCapital Medical University
- RECRUITINGNANCT07380789Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in UkraineLviv National Medical University
- RECRUITINGPHASE2, PHASE3NCT07342205A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota TransplantationShanghai University of Traditional Chinese Medicine
- RECRUITINGPHASE3NCT07208591To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress SyndromeStaidson (Beijing) Biopharmaceuticals Co., Ltd
- RECRUITINGPHASE2NCT06513949Anti-CD14 Treatment With IC14 in Hospitalized ARDS PatientsImplicit Bioscience
- RECRUITINGPHASE2NCT06703073JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)PPD Development, LP
- RECRUITINGPHASE1, PHASE2NCT07413978A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress SyndromeChangchun Tuohua Pharmaceutical Co., Ltd.
- RECRUITINGNANCT06772025A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung MachineBayer